Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
MLC901
DRUG
3 trials
Sponsors
National University Hospital, Singapore
, University of the Philippines
Conditions
Alzheimer Disease
Cognitive Impairment
Moderate Traumatic Brain Injury
Phase 2
NEURoaid II (MLC 901) Assessment in Cognitively Impaired Not Demented Subjects
Completed
NCT01847924
National University Hospital, Singapore
Cognitive Impairment
Start: 2013-03-31
End: 2018-04-30
Updated: 2018-07-27
The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study
NCT03038035
National University Hospital, Singapore
Alzheimer Disease
Start: 2016-12-31
End: 2019-06-30
Target: 150
Updated: 2017-01-31
Phase 4
MLC901 in Moderate Traumatic Brain Injury
NCT04766281
University of the Philippines
Moderate Traumatic Brain Injury
Start: 2021-05-01
End: 2024-07-31
Target: 120
Updated: 2023-06-13
Related Papers
Alzheimer's Disease THErapy With NEuroaid (ATHENE): A Randomized Double-Blind Delayed-Start Trial.
2021-11-29
12 citations